首页 > 最新文献

International Journal of Endocrinology and Metabolism最新文献

英文 中文
Sphingosine Kinase 2 Knockout Mice Resist HFD-Induced Obesity Through Increasing Energy Expenditure. 鞘氨醇激酶2敲除小鼠通过增加能量消耗抵抗hfd诱导的肥胖
IF 2.1 Q3 Medicine Pub Date : 2023-07-30 eCollection Date: 2023-07-01 DOI: 10.5812/ijem-136539
Jiawei Zhao, Menq-Jer Lee

Background: It has been reported that sphingosine kinase (SK) 2 plays a role in maintaining metabolism and glucose homeostasis. However, the mechanism remains uncertain.

Objectives: The present research aimed to further investigate the effect of SK2 knockout on high-fat diet (HFD)-induced obesity and metabolic regulation.

Methods: Male SK2-/- and wild-type (WT) control mice were challenged with HFD for 8 weeks. Then, body composition, inguinal white adipose tissue (IWAT) histology, intraperitoneal glucose tolerance tests (IPGTT), and metabolic parameters were examined, and expression levels of uncoupling protein 1 (UCP1), a key molecular marker of thermogenesis, in IWAT were determined.

Results: After 8 weeks of HFD challenge, compared with WT mice, SK2-/- mice displayed decreased whole body, epididymal white adipose tissue (EWAT) and IWAT weights, reduced fat/lean body mass ratios and inguinal adipocytes size; also, SK2-/- mice exhibited improved intraperitoneal glucose tolerance. Next, elevated energy expenditure was observed in SK2-/- mice compared with WT mice; however, neither food intake nor physical activity showed obvious difference between SK2-/- and WT mice. Furthermore, we found that the expressions of UCP1 was markedly increased in IWAT from SK2-/- mice.

Conclusions: SK2-/- mice may resist HFD-induced obesity through increasing energy expenditure by promoting thermogenesis in the beige adipose tissue.

背景:据报道,鞘氨醇激酶(SK)2在维持代谢和葡萄糖稳态中发挥作用,但其机制尚不确定。目的:本研究旨在进一步研究SK2基因敲除对高脂饮食(HFD)诱导的肥胖和代谢调节的影响。方法:雄性SK2−/−和野生型(WT)对照小鼠用HFD攻击8周,然后检查身体组成、腹股沟白色脂肪组织(IWAT)组织学、腹膜内葡萄糖耐量试验(IPGTT)和代谢参数,并测定产热关键分子标记物解偶联蛋白1(UCP1)在IWAT中的表达水平。结果:在HFD攻击8周后,与WT小鼠相比,SK2−/-小鼠表现出全身、附睾白色脂肪组织(EWAT)和IWAT重量减少,脂肪/瘦体质量比和腹股沟脂肪细胞大小减少;此外,SK2-/-小鼠表现出改善的腹膜内葡萄糖耐受性。其次,与WT小鼠相比,SK2--/-小鼠的能量消耗增加;然而,在SK2-/-和WT小鼠之间,无论是食物摄入还是体力活动都没有显示出明显的差异。此外,我们发现,在SK2//-小鼠的IWAT中,UCP1的表达显著增加。结论:SK2-/-小鼠可以通过促进米色脂肪组织的产热来增加能量消耗,从而抵抗HFD诱导的肥胖。
{"title":"Sphingosine Kinase 2 Knockout Mice Resist HFD-Induced Obesity Through Increasing Energy Expenditure.","authors":"Jiawei Zhao, Menq-Jer Lee","doi":"10.5812/ijem-136539","DOIUrl":"10.5812/ijem-136539","url":null,"abstract":"<p><strong>Background: </strong>It has been reported that sphingosine kinase (SK) 2 plays a role in maintaining metabolism and glucose homeostasis. However, the mechanism remains uncertain.</p><p><strong>Objectives: </strong>The present research aimed to further investigate the effect of SK2 knockout on high-fat diet (HFD)-induced obesity and metabolic regulation.</p><p><strong>Methods: </strong>Male SK2-/- and wild-type (WT) control mice were challenged with HFD for 8 weeks. Then, body composition, inguinal white adipose tissue (IWAT) histology, intraperitoneal glucose tolerance tests (IPGTT), and metabolic parameters were examined, and expression levels of uncoupling protein 1 (UCP1), a key molecular marker of thermogenesis, in IWAT were determined.</p><p><strong>Results: </strong>After 8 weeks of HFD challenge, compared with WT mice, SK2-/- mice displayed decreased whole body, epididymal white adipose tissue (EWAT) and IWAT weights, reduced fat/lean body mass ratios and inguinal adipocytes size; also, SK2-/- mice exhibited improved intraperitoneal glucose tolerance. Next, elevated energy expenditure was observed in SK2-/- mice compared with WT mice; however, neither food intake nor physical activity showed obvious difference between SK2-/- and WT mice. Furthermore, we found that the expressions of UCP1 was markedly increased in IWAT from SK2-/- mice.</p><p><strong>Conclusions: </strong>SK2-/- mice may resist HFD-induced obesity through increasing energy expenditure by promoting thermogenesis in the beige adipose tissue.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46593088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report. 后可逆性脑病综合征作为Lenvatinib对甲状腺乳头状癌患者的不良反应:1例报告。
IF 2.1 Q3 Medicine Pub Date : 2023-07-29 eCollection Date: 2023-07-01 DOI: 10.5812/ijem-136900
Daisy Carolina Buenaventura, Hernando Vargas-Sierra, Natalia Aristizabal-Henao, Jose Luis Torres-Grajales, Carolina Aguilar-Londono, Johnayro Gutierrez-Restrepo

Posterior reversible encephalopathy syndrome (PRES) is an uncommon transient neuroradiological phenomenon that develops vasogenic cerebral edema and could be caused by some pharmacological agents, such as molecular-specific target agents. Lenvatinib belongs to the tyrosine kinase inhibitors and was approved in 2015 for progressive locally advanced or metastatic thyroid cancer refractory to radioactive iodine (I-131) treatment. Herein, we present the case of a 65-year-old woman who, while receiving treatment with lenvatinib for radioiodine-refractory metastatic papillary thyroid carcinoma, developed PRES without hypertension at the initial evaluation. Her clinical and radiological findings improved after withdrawing from the mentioned therapy, and later it was possible to re-incorporate lower doses of the medication, as described in the other three case reports found in the worldwide medical literature. The recognition of this entity is essential to timely suspend the drug and avoid greater comorbidity. This is the first paper reporting this kind of adverse event using lenvatinib in a Hispanic population.

后可逆性脑病综合征(PRES)是一种罕见的一过性神经放射学现象,可发展为血管源性脑水肿,可能由某些药物引起,如分子特异性靶标药物。Lenvatinib属于酪氨酸激酶抑制剂,于2015年被批准用于对放射性碘(I-131)治疗难治的进行性局部晚期或转移性甲状腺癌。在此,我们报告了一位65岁的女性,她在接受lenvatinib治疗放射性碘难治性转移性甲状腺乳头状癌时,在最初的评估中出现了PRES,但没有高血压。她的临床和放射学表现在停止上述治疗后有所改善,后来有可能重新加入较低剂量的药物,如世界医学文献中发现的其他三例病例报告所述。承认这一实体对于及时停药和避免更大的合并症至关重要。这是第一篇报道在西班牙裔人群中使用lenvatinib的此类不良事件的论文。
{"title":"Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report.","authors":"Daisy Carolina Buenaventura, Hernando Vargas-Sierra, Natalia Aristizabal-Henao, Jose Luis Torres-Grajales, Carolina Aguilar-Londono, Johnayro Gutierrez-Restrepo","doi":"10.5812/ijem-136900","DOIUrl":"10.5812/ijem-136900","url":null,"abstract":"<p><p>Posterior reversible encephalopathy syndrome (PRES) is an uncommon transient neuroradiological phenomenon that develops vasogenic cerebral edema and could be caused by some pharmacological agents, such as molecular-specific target agents. Lenvatinib belongs to the tyrosine kinase inhibitors and was approved in 2015 for progressive locally advanced or metastatic thyroid cancer refractory to radioactive iodine (I-131) treatment. Herein, we present the case of a 65-year-old woman who, while receiving treatment with lenvatinib for radioiodine-refractory metastatic papillary thyroid carcinoma, developed PRES without hypertension at the initial evaluation. Her clinical and radiological findings improved after withdrawing from the mentioned therapy, and later it was possible to re-incorporate lower doses of the medication, as described in the other three case reports found in the worldwide medical literature. The recognition of this entity is essential to timely suspend the drug and avoid greater comorbidity. This is the first paper reporting this kind of adverse event using lenvatinib in a Hispanic population.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71265597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves' Disease and Methimazole-Induced Liver Injury. 治疗性血浆置换作为甲巯咪唑所致肝损伤患者决定性治疗的桥接疗法
IF 2.1 Q3 Medicine Pub Date : 2023-07-18 eCollection Date: 2023-07-01 DOI: 10.5812/ijem-136608
Dyah Purnamasari, Ardy Wildan, Juferdy Kurniawan, Nadia Ayu Mulansari, Birry Karim, Erwin Danil Yulian

Introduction: Graves' disease (GD) is an autoimmune condition affecting the thyroid gland. The aim of treating GD is to control the symptoms of hyperthyroidism and achieve long-term remission. Antithyroid drugs (ATDs) are the medications of choice among newly-diagnosed GD patients as they are easy to be delivered and cause remission in more than 50% of patients. However, ATDs increase the risk of hepatotoxicity, especially among patients with liver abnormalities. Patients who cannot tolerate ATDs should receive definitive therapy such as radioactive iodine (RAI) or surgery. In order to minimize the risk of thyroid storm during these procedures, patients should be in euthyroid condition and receive bridging therapy. Therapeutic plasma exchange (TPE), which aims to remove thyroid hormones from plasma, is one of the modalities that can be considered as a bridging therapy during the perioperative period among GD patients who cannot tolerate ATD.

Case presentation: A 35-year-old man with general weakness and thyrotoxicosis symptoms was admitted to the emergency room. Lid retraction, diffuse Goiter, and tremors were evident. Laboratory findings revealed TSH = 0.005 µIU/mL, FT4 = 7.77 ng/dL, TRAb = 9.90 IU/L, ALT = 123 U/L, total bilirubin = 23.94 µmol/L, and direct bilirubin = 10.26 µmol/L. Ultrasonographic examination showed the enlargement of the thyroid gland, and abdomen ultrasonographic evaluation showed mild hepatomegaly with mild fatty infiltration. The patient was diagnosed with GD, suspected thyroid storm, elevated liver transaminases, and fatty liver disease. The patient then received methimazole, propranolol, and glycyrrhizin. During observation, the patient developed drug-induced liver injury (DILI) evidenced by an increase in liver enzymes (ALT up to 1023 U/L) and the elevation of total bilirubin to 258.21 µmol/L, so methimazole was stopped. After discontinuing methimazole, liver injury improved. However, thyrotoxicosis symptoms returned, so the patient underwent a total thyroidectomy. In order to achieve a euthyroid status before surgery, five sessions of therapeutic plasma exchange were performed, which improved the signs and symptoms of hyperthyroidism and retained the thyroxine hormone within the normal range. Thyroidectomy was then performed successfully without serious complications (e.g., thyroid storm, etc.).

Conclusions: Therapeutic plasma exchange is a safe and effective bridging therapy for GD patients who require thyroidectomy but cannot tolerate ATDs.

格雷夫斯病(GD)是一种影响甲状腺的自身免疫性疾病。治疗GD的目的是控制甲状腺机能亢进的症状,达到长期缓解。抗甲状腺药物(ATDs)是新诊断的GD患者的首选药物,因为它们易于递送,并在50%以上的患者中引起缓解。然而,ATDs增加了肝毒性的风险,特别是在肝脏异常的患者中。不能耐受ATDs的患者应接受明确的治疗,如放射性碘(RAI)或手术。为了使这些手术过程中甲状腺风暴的风险降到最低,患者应处于甲状腺功能正常状态并接受桥接治疗。治疗性血浆置换(TPE)旨在从血浆中去除甲状腺激素,是不能耐受ATD的GD患者围手术期的一种桥接治疗方式。病例介绍:一名35岁男性,全身虚弱并有甲状腺功能亢进症状,被送往急诊室。眼睑收缩,弥漫性甲状腺肿大,震颤明显。TSH = 0.005 μ IU/mL, FT4 = 7.77 ng/dL, TRAb = 9.90 IU/L, ALT = 123 U/L,总胆红素= 23.94 μ mol/L,直接胆红素= 10.26 μ mol/L。超声检查显示甲状腺肿大,腹部超声检查显示轻度肝肿大伴轻度脂肪浸润。诊断为GD,疑似甲状腺风暴,肝转氨酶升高,脂肪肝。然后给予甲巯咪唑、心得安、地塞米松、甘草酸。观察期间,患者出现药物性肝损伤(DILI),肝酶升高(ALT达1023 U/L),总胆红素升高至258.21µmol/L,停用甲巯咪唑。停服甲巯咪唑后,肝损伤改善。然而,甲状腺毒症症状复发,因此患者接受了全甲状腺切除术。为了在手术前达到甲状腺功能正常状态,进行了5次治疗性血浆交换(TPE),改善了甲亢的体征和症状,并将甲状腺素保持在正常范围内。甲状腺切除术成功,无严重并发症(如甲状腺风暴等)。结论:治疗性血浆置换对于需要甲状腺切除术但不能耐受ATDs的GD患者是一种安全有效的桥接治疗。
{"title":"Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves' Disease and Methimazole-Induced Liver Injury.","authors":"Dyah Purnamasari, Ardy Wildan, Juferdy Kurniawan, Nadia Ayu Mulansari, Birry Karim, Erwin Danil Yulian","doi":"10.5812/ijem-136608","DOIUrl":"10.5812/ijem-136608","url":null,"abstract":"<p><strong>Introduction: </strong>Graves' disease (GD) is an autoimmune condition affecting the thyroid gland. The aim of treating GD is to control the symptoms of hyperthyroidism and achieve long-term remission. Antithyroid drugs (ATDs) are the medications of choice among newly-diagnosed GD patients as they are easy to be delivered and cause remission in more than 50% of patients. However, ATDs increase the risk of hepatotoxicity, especially among patients with liver abnormalities. Patients who cannot tolerate ATDs should receive definitive therapy such as radioactive iodine (RAI) or surgery. In order to minimize the risk of thyroid storm during these procedures, patients should be in euthyroid condition and receive bridging therapy. Therapeutic plasma exchange (TPE), which aims to remove thyroid hormones from plasma, is one of the modalities that can be considered as a bridging therapy during the perioperative period among GD patients who cannot tolerate ATD.</p><p><strong>Case presentation: </strong>A 35-year-old man with general weakness and thyrotoxicosis symptoms was admitted to the emergency room. Lid retraction, diffuse Goiter, and tremors were evident. Laboratory findings revealed TSH = 0.005 µIU/mL, FT4 = 7.77 ng/dL, TRAb = 9.90 IU/L, ALT = 123 U/L, total bilirubin = 23.94 µmol/L, and direct bilirubin = 10.26 µmol/L. Ultrasonographic examination showed the enlargement of the thyroid gland, and abdomen ultrasonographic evaluation showed mild hepatomegaly with mild fatty infiltration. The patient was diagnosed with GD, suspected thyroid storm, elevated liver transaminases, and fatty liver disease. The patient then received methimazole, propranolol, and glycyrrhizin. During observation, the patient developed drug-induced liver injury (DILI) evidenced by an increase in liver enzymes (ALT up to 1023 U/L) and the elevation of total bilirubin to 258.21 µmol/L, so methimazole was stopped. After discontinuing methimazole, liver injury improved. However, thyrotoxicosis symptoms returned, so the patient underwent a total thyroidectomy. In order to achieve a euthyroid status before surgery, five sessions of therapeutic plasma exchange were performed, which improved the signs and symptoms of hyperthyroidism and retained the thyroxine hormone within the normal range. Thyroidectomy was then performed successfully without serious complications (e.g., thyroid storm, etc.).</p><p><strong>Conclusions: </strong>Therapeutic plasma exchange is a safe and effective bridging therapy for GD patients who require thyroidectomy but cannot tolerate ATDs.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41276064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Long-term Ovariectomy Reduces Tolerance of Rats to Myocardial Ischemia-reperfusion Injury. 长期卵巢切除术降低大鼠心肌缺血再灌注损伤耐受性
IF 2.1 Q3 Medicine Pub Date : 2023-06-21 eCollection Date: 2023-07-01 DOI: 10.5812/ijem-135101
Nasibeh Yousefzadeh, Sajad Jeddi

Background: The harmful impact of ovariectomy on myocardial ischemia-reperfusion (M/IR) injury has been established in the short term.

Objectives: In this study, we aimed to investigate the long-term effects of ovariectomy on M/IR injury.

Methods: Two methods involving dorsolateral skin incisions were used to induce the ovariectomized (OVX) rat model. The rats were divided into 2 groups: Control and OVX (n = 6). At the end of the study, the hearts were isolated and subjected to global ischemia using the Langendorff apparatus. Cardiac function indices (CFIs) were recorded, including left ventricular end-diastolic pressure (LVEDP), peak rates of positive (+dp/dt) and negative (-dp/dt) changes in LV pressure, and LV-developed pressure (LVDP). At the end of the reperfusion period, the hearts were used to measure the size of the infarct, levels of nitric oxide metabolites (NOx), and mRNA expression of NO synthase (NOS) enzymes, including endothelial (eNOS), neuronal (nNOS), and inducible (iNOS).

Results: Compared to controls, OVX rats had larger infarct size by 51%, higher LVEDP by 29%, and lower recovery of +dp/dt, -dp/dt, and LVDP by 29%, 22%, and 35%, respectively. Furthermore, in heart tissue, rats that underwent OVX had significantly higher concentrations of nitrate, nitrite, and NOx by 79%, 82%, and 83%, respectively. Additionally, these rats had lower mRNA levels of eNOS by 38% and higher mRNA levels of iNOS by 71%.

Conclusions: The long-term deficiency of estrogen increased the expression of iNOS and decreased the expression of eNOS in the heart tissue of OVX rats. Imbalanced NOS expressions were associated with exacerbated responses to M/IR injury in OVX rats.

背景:卵巢切除术对心肌缺血再灌注(M/IR)损伤的有害影响在短期内已经确立。目的:在本研究中,我们旨在探讨卵巢切除术对M/IR损伤的长期影响。方法:采用两种方法,均涉及背外侧皮肤切口,建立去卵巢大鼠模型。将大鼠分为对照组和OVX组(n = 6)。实验结束时,取离体心脏,Langendorff仪进行全心缺血处理。记录心功能指标(CFIs),包括左室舒张末期压(LVEDP)、左室压正(+dp/dt)和负(-dp/dt)变化峰值率、左室发展压(LVDP)。在再灌注期结束时,测量心肌梗死面积、一氧化氮代谢产物(NOx)水平和一氧化氮合成酶(NOS) mRNA表达,包括内皮(eNOS)、神经元(nNOS)和诱导(iNOS)。结果:与对照组相比,OVX大鼠的梗死面积增加51%,LVEDP增加29%,+dp/dt、-dp /dt和LVDP的恢复分别降低29%、22%和35%。此外,在心脏组织中,接受OVX治疗的大鼠的硝酸盐、亚硝酸盐和氮氧化物浓度分别显著提高了79%、82%和83%。此外,这些大鼠eNOS mRNA水平降低了38%,iNOS mRNA水平升高了71%。结论:长期缺乏雌激素可使OVX大鼠心脏组织中iNOS表达升高,eNOS表达降低。不平衡的NOS表达与OVX大鼠对M/IR损伤的反应加剧有关。
{"title":"Long-term Ovariectomy Reduces Tolerance of Rats to Myocardial Ischemia-reperfusion Injury.","authors":"Nasibeh Yousefzadeh, Sajad Jeddi","doi":"10.5812/ijem-135101","DOIUrl":"10.5812/ijem-135101","url":null,"abstract":"<p><strong>Background: </strong>The harmful impact of ovariectomy on myocardial ischemia-reperfusion (M/IR) injury has been established in the short term.</p><p><strong>Objectives: </strong>In this study, we aimed to investigate the long-term effects of ovariectomy on M/IR injury.</p><p><strong>Methods: </strong>Two methods involving dorsolateral skin incisions were used to induce the ovariectomized (OVX) rat model. The rats were divided into 2 groups: Control and OVX (n = 6). At the end of the study, the hearts were isolated and subjected to global ischemia using the Langendorff apparatus. Cardiac function indices (CFIs) were recorded, including left ventricular end-diastolic pressure (LVEDP), peak rates of positive (+dp/dt) and negative (-dp/dt) changes in LV pressure, and LV-developed pressure (LVDP). At the end of the reperfusion period, the hearts were used to measure the size of the infarct, levels of nitric oxide metabolites (NOx), and mRNA expression of NO synthase (NOS) enzymes, including endothelial (eNOS), neuronal (nNOS), and inducible (iNOS).</p><p><strong>Results: </strong>Compared to controls, OVX rats had larger infarct size by 51%, higher LVEDP by 29%, and lower recovery of +dp/dt, -dp/dt, and LVDP by 29%, 22%, and 35%, respectively. Furthermore, in heart tissue, rats that underwent OVX had significantly higher concentrations of nitrate, nitrite, and NOx by 79%, 82%, and 83%, respectively. Additionally, these rats had lower mRNA levels of eNOS by 38% and higher mRNA levels of iNOS by 71%.</p><p><strong>Conclusions: </strong>The long-term deficiency of estrogen increased the expression of iNOS and decreased the expression of eNOS in the heart tissue of OVX rats. Imbalanced NOS expressions were associated with exacerbated responses to M/IR injury in OVX rats.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48061587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Diabetic Ketoacidosis Characteristics During- and Before the COVID-19 Pandemic. 新冠肺炎大流行前后糖尿病酮酸样变性特征的比较
IF 2.1 Q3 Medicine Pub Date : 2023-06-18 eCollection Date: 2023-07-01 DOI: 10.5812/ijem-134882
Nastaran Injinari, Hamed Ghoshouni, Akram Mehrabbeik, Nasim Namiranian, Akram Ghadiri-Anari, Reyhaneh Azizi

Background: Despite evidence about the relationship between diabetic ketoacidosis (DKA) and infectious diseases, our knowledge of DKA during the coronavirus disease 2019 (COVID-19) pandemic remains unclear.

Objectives: This study aimed to compare the DKA situation among individuals with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) during the COVID-19 pandemic compared to pre-pandemic.

Methods: This retrospective-longitudinal study included individuals with T1DM and T2DM hospitalized with newly diagnosed DKA before (March to August 2018 and 2019) and during (March to August 2020 and 2021) the COVID-19 pandemic. Demographics, the frequency of new-onset diabetes mellitus (DM) and new-onset DKA, days of hospitalization, DKA severity, laboratory tests, and mortality were assessed.

Results: Of 162 patients with DKA, 139 patients were newly diagnosed. The frequency of individuals with new-onset DM had increased during the pandemic compared to pre-pandemic (P = 0.047). Moreover, new-onset DKA was higher in 2020 and 2021 versus 2019 and 2018 (P = 0.002). Significantly, there were no T2DM patients with DKA in pre-pandemic, but DKA admissions in people with T2DM increased in 2021 (P < 0.001). The severity of new-onset DKA had increased during the pandemic compared to pre-pandemic (P = 0.000). However, there was no significant difference between pre-and the pandemic regarding mortality (P = 0.981). Additionally, hospitalization length (P = 0.043) and mortality (P = 0.038) were higher in patients with T2DM compared to T1DM.

Conclusions: During the COVID-19 pandemic, the frequency of DKA and its severity was higher than in pre-pandemic, and COVID-19 can be more life-threatening in patients with T2DM. Therefore, healthcare providers should be alert to DKA, especially in patients with T2DM.

背景:尽管有证据表明糖尿病酮酸中毒(DKA)与传染病之间存在关系,但我们在2019冠状病毒病(新冠肺炎)大流行期间对DKA的了解仍不清楚。目的:本研究旨在比较新冠肺炎大流行期间1型糖尿病(T1DM)和2型糖尿病(T2DM)患者与大流行前的DKA情况。方法:这项回顾性纵向研究包括在新冠肺炎大流行之前(2018年3月至8月和2019年8月)和期间(2020年3月到8月和2021年)因新诊断DKA住院的T1DM和T2DM患者。评估人口统计学、新发糖尿病(DM)和新发DKA的频率、住院天数、DKA严重程度、实验室检查和死亡率。结果:162例DKA患者中,139例为新诊断。与疫情前相比,新发DM患者的发病率在疫情期间有所增加(P=0.047)。此外,与2019年和2018年相比,2020年和2021年新发DKA更高(P=0.002)。值得注意的是,疫情前没有患有DKA的T2DM患者,但2021年T2DM患者的DKA入院人数增加(P<0.001)。与疫情前相比,新发DKA的严重程度在疫情期间有所增加(P=0.000)。然而,在死亡率方面,疫情前和疫情前没有显著差异(P=0.981)。此外,T2DM患者的住院时间(P=0.043)和死亡率(P=0.038)高于T1DM患者。结论:在新冠肺炎大流行期间,DKA的发生频率及其严重程度高于大流行前,新冠肺炎对T2DM患者的威胁更大。因此,医疗保健提供者应警惕DKA,尤其是T2DM患者。
{"title":"Comparison of Diabetic Ketoacidosis Characteristics During- and Before the COVID-19 Pandemic.","authors":"Nastaran Injinari, Hamed Ghoshouni, Akram Mehrabbeik, Nasim Namiranian, Akram Ghadiri-Anari, Reyhaneh Azizi","doi":"10.5812/ijem-134882","DOIUrl":"10.5812/ijem-134882","url":null,"abstract":"<p><strong>Background: </strong>Despite evidence about the relationship between diabetic ketoacidosis (DKA) and infectious diseases, our knowledge of DKA during the coronavirus disease 2019 (COVID-19) pandemic remains unclear.</p><p><strong>Objectives: </strong>This study aimed to compare the DKA situation among individuals with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) during the COVID-19 pandemic compared to pre-pandemic.</p><p><strong>Methods: </strong>This retrospective-longitudinal study included individuals with T1DM and T2DM hospitalized with newly diagnosed DKA before (March to August 2018 and 2019) and during (March to August 2020 and 2021) the COVID-19 pandemic. Demographics, the frequency of new-onset diabetes mellitus (DM) and new-onset DKA, days of hospitalization, DKA severity, laboratory tests, and mortality were assessed.</p><p><strong>Results: </strong>Of 162 patients with DKA, 139 patients were newly diagnosed. The frequency of individuals with new-onset DM had increased during the pandemic compared to pre-pandemic (P = 0.047). Moreover, new-onset DKA was higher in 2020 and 2021 versus 2019 and 2018 (P = 0.002). Significantly, there were no T2DM patients with DKA in pre-pandemic, but DKA admissions in people with T2DM increased in 2021 (P < 0.001). The severity of new-onset DKA had increased during the pandemic compared to pre-pandemic (P = 0.000). However, there was no significant difference between pre-and the pandemic regarding mortality (P = 0.981). Additionally, hospitalization length (P = 0.043) and mortality (P = 0.038) were higher in patients with T2DM compared to T1DM.</p><p><strong>Conclusions: </strong>During the COVID-19 pandemic, the frequency of DKA and its severity was higher than in pre-pandemic, and COVID-19 can be more life-threatening in patients with T2DM. Therefore, healthcare providers should be alert to DKA, especially in patients with T2DM.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48428316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study. 新冠肺炎大流行前和期间儿童糖尿病酮酸中毒:一项跨部门研究。
IF 2.1 Q3 Medicine Pub Date : 2023-04-03 eCollection Date: 2023-04-01 DOI: 10.5812/ijem-132809
Mahtab Ordooei, Mehran Karimi, Elahe Akbarian, Zahra Rasoulizadeh
Background Coronavirus disease 2019 (COVID-19) has spread quickly. Comorbidities, such as diabetes, have been determined as critical risk factors for COVID-19. Objectives This study aimed to determine the frequency and severity of diabetic ketoacidosis (DKA) in children before and during the COVID-19 pandemic. Methods This retrospective study examined children aged less than 18 years diagnosed with DKA hospitalized in Yazd Shahid Sadoughi Hospital from February 20, 2020, to November 21, 2021. The collected information was compared to those obtained during the same period in 2019 (pre-pandemic). According to the inclusion criteria, only children with suspected symptoms of COVID-19 or an infected family member underwent PCR. Results The study included 70 children with confirmed DKA during the COVID-19 pandemic and 33 children hospitalized during the pre-pandemic period. The findings showed that the rate of DKA was higher during the pandemic than in the pre-pandemic period. In the DKA subgroups (during the COVID-19 pandemic vs. pre-pandemic), 35.7% vs. 21.2% were severe, 37.1% vs. 36.4% were moderate, and 27.1% vs. 42.4% were mild. Of 70 children, 30 underwent PCR tests for COVID-19, showing six positive cases. Among positive cases, five had mild symptoms, while one was hospitalized with signs of respiratory distress, polyuria, and polydipsia. All physical examinations of this patient were normal, except for the chest exam. Conclusions A remarkable increase was observed in the frequency and severity of DKA in children during the pandemic.
背景:2019冠状病毒病(新冠肺炎)迅速蔓延。糖尿病等合并症已被确定为新冠肺炎的关键危险因素。目的:本研究旨在确定新冠肺炎大流行前和期间儿童糖尿病酮酸中毒(DKA)的频率和严重程度。方法:这项回顾性研究检查了2020年2月20日至2021年11月21日在亚兹德·沙希德·萨杜吉医院住院的18岁以下诊断为DKA的儿童。将收集到的信息与2019年同期(疫情前)获得的信息进行了比较。根据纳入标准,只有有新冠肺炎疑似症状的儿童或受感染的家庭成员才接受PCR。结果:该研究包括70名在新冠肺炎大流行期间确诊DKA的儿童和33名在大流行前住院的儿童。研究结果表明,在疫情期间,DKA的发病率高于疫情前。在DKA亚组中(在新冠肺炎大流行期间与大流行前),35.7%对21.2%为重度,37.1%对36.4%为中度,27.1%对42.4%为轻度。在70名儿童中,30人接受了新冠肺炎PCR检测,显示6例阳性病例。在阳性病例中,5例症状轻微,1例因呼吸窘迫、多尿和多饮症状住院。除胸部检查外,该患者的所有身体检查均正常。结论:在疫情期间,儿童DKA的频率和严重程度显著增加。
{"title":"Diabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study.","authors":"Mahtab Ordooei,&nbsp;Mehran Karimi,&nbsp;Elahe Akbarian,&nbsp;Zahra Rasoulizadeh","doi":"10.5812/ijem-132809","DOIUrl":"10.5812/ijem-132809","url":null,"abstract":"Background Coronavirus disease 2019 (COVID-19) has spread quickly. Comorbidities, such as diabetes, have been determined as critical risk factors for COVID-19. Objectives This study aimed to determine the frequency and severity of diabetic ketoacidosis (DKA) in children before and during the COVID-19 pandemic. Methods This retrospective study examined children aged less than 18 years diagnosed with DKA hospitalized in Yazd Shahid Sadoughi Hospital from February 20, 2020, to November 21, 2021. The collected information was compared to those obtained during the same period in 2019 (pre-pandemic). According to the inclusion criteria, only children with suspected symptoms of COVID-19 or an infected family member underwent PCR. Results The study included 70 children with confirmed DKA during the COVID-19 pandemic and 33 children hospitalized during the pre-pandemic period. The findings showed that the rate of DKA was higher during the pandemic than in the pre-pandemic period. In the DKA subgroups (during the COVID-19 pandemic vs. pre-pandemic), 35.7% vs. 21.2% were severe, 37.1% vs. 36.4% were moderate, and 27.1% vs. 42.4% were mild. Of 70 children, 30 underwent PCR tests for COVID-19, showing six positive cases. Among positive cases, five had mild symptoms, while one was hospitalized with signs of respiratory distress, polyuria, and polydipsia. All physical examinations of this patient were normal, except for the chest exam. Conclusions A remarkable increase was observed in the frequency and severity of DKA in children during the pandemic.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c3/8b/ijem-21-2-132809.PMC10474797.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10524568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes Ketoacidosis and COVID-19: An Insight into the Pathophysiology. 糖尿病酮症酸中毒与COVID-19:病理生理学的洞察。
IF 2.1 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5812/ijem-133631
Seyed Amirabbas Ahadiat, Zeinab Hosseinian
{"title":"Diabetes Ketoacidosis and COVID-19: An Insight into the Pathophysiology.","authors":"Seyed Amirabbas Ahadiat,&nbsp;Zeinab Hosseinian","doi":"10.5812/ijem-133631","DOIUrl":"https://doi.org/10.5812/ijem-133631","url":null,"abstract":"<jats:p />","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/8d/ijem-21-2-133631.PMC10467579.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10659944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Metformin in COVID-19: Is There a Role Beyond Glycemic Control? 二甲双胍在COVID-19中的作用:除了控制血糖之外还有其他作用吗?
IF 2.1 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5812/ijem-132965
Lakshmi Nagendra, Saptarshi Bhattacharya, Sanjay Kalra, Nitin Kapoor

Context: The coronavirus disease 2019 (COVID-19) pandemic is still a cause of worldwide health concern. Diabetes and its associated comorbidities are risk factors for mortality and morbidity in COVID-19. Selecting the right antidiabetic drug to achieve optimal glycemic control might mitigate some of the negative impacts of diabetes. Metformin continues to be the most widely administered antidiabetic agent. There is evidence of its beneficial outcome in COVID-19 independent of its glucose-lowering effect.

Evidence acquisition: A thorough literature search was conducted in PubMed, Google Scholar, Scopus, and Web of Science to identify studies investigating metformin in COVID-19.

Results: Several overlapping mechanisms have been proposed to explain its antiviral properties. It could bring about conformational changes in the angiotensin-converting enzyme-2 receptor and decrease viral entry. The effects on the mammalian target of the rapamycin pathway and cellular pH have been proposed to reduce viral protein synthesis and replication. The immunomodulatory effects of metformin might counter the detrimental effects of hyperinflammation associated with COVID-19.

Conclusions: These findings call for broader metformin usage to manage hyperglycemia in COVID-19.

背景:2019冠状病毒病(COVID-19)大流行仍然是全球健康关注的一个原因。糖尿病及其相关合并症是COVID-19患者死亡和发病的危险因素。选择正确的降糖药来达到最佳的血糖控制可能会减轻糖尿病的一些负面影响。二甲双胍仍然是最广泛使用的降糖药。有证据表明其在COVID-19中的有益结果独立于其降血糖作用。证据获取:在PubMed、Google Scholar、Scopus和Web of Science中进行了全面的文献检索,以确定调查二甲双胍在COVID-19中的作用的研究。结果:提出了几种重叠机制来解释其抗病毒特性。它可以引起血管紧张素转换酶-2受体的构象改变,减少病毒的进入。雷帕霉素途径对哺乳动物靶点和细胞pH的影响已被提出,以减少病毒蛋白的合成和复制。二甲双胍的免疫调节作用可能会抵消与COVID-19相关的过度炎症的有害影响。结论:这些发现呼吁更广泛地使用二甲双胍来控制COVID-19患者的高血糖。
{"title":"Metformin in COVID-19: Is There a Role Beyond Glycemic Control?","authors":"Lakshmi Nagendra,&nbsp;Saptarshi Bhattacharya,&nbsp;Sanjay Kalra,&nbsp;Nitin Kapoor","doi":"10.5812/ijem-132965","DOIUrl":"https://doi.org/10.5812/ijem-132965","url":null,"abstract":"<p><strong>Context: </strong>The coronavirus disease 2019 (COVID-19) pandemic is still a cause of worldwide health concern. Diabetes and its associated comorbidities are risk factors for mortality and morbidity in COVID-19. Selecting the right antidiabetic drug to achieve optimal glycemic control might mitigate some of the negative impacts of diabetes. Metformin continues to be the most widely administered antidiabetic agent. There is evidence of its beneficial outcome in COVID-19 independent of its glucose-lowering effect.</p><p><strong>Evidence acquisition: </strong>A thorough literature search was conducted in PubMed, Google Scholar, Scopus, and Web of Science to identify studies investigating metformin in COVID-19.</p><p><strong>Results: </strong>Several overlapping mechanisms have been proposed to explain its antiviral properties. It could bring about conformational changes in the angiotensin-converting enzyme-2 receptor and decrease viral entry. The effects on the mammalian target of the rapamycin pathway and cellular pH have been proposed to reduce viral protein synthesis and replication. The immunomodulatory effects of metformin might counter the detrimental effects of hyperinflammation associated with COVID-19.</p><p><strong>Conclusions: </strong>These findings call for broader metformin usage to manage hyperglycemia in COVID-19.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/a7/ijem-21-2-132965.PMC10467582.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10127539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-reported Male Infertility and Metabolic Disturbance: A Cross-Sectional Study. 自我报告的男性不育症和代谢紊乱:一项横断面研究。
IF 2.1 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5812/ijem-134895
Mahbanoo Farhadi-Azar, Marzieh Saei Ghare Naz, Mehrdad Ghahremani, Maryam Mousavi, Fereidoun Azizi, Fahimeh Ramezani Tehrani

Background: Male infertility is a growing health problem. It is proposed that infertility is associated with some metabolic abnormalities.

Objectives: This study aimed to examine the prevalence of self-reported male infertility and related metabolic disturbances.

Methods: This is a cross-sectional analysis of the Tehran Lipid and Glucose Study (TLGS). A total of 1526 males participated in the study. Logistic regression was used to examine metabolic factors associated with self-reported male infertility.

Results: The total prevalence of self-reported male infertility was 6.42%. The mean (SD) body mass index (BMI) of participants among fertile and infertile males was 26.80 (3.93) and 26.92 (4.36), respectively. The majority of participants in both groups were in the age group of 40-50 years old. In the fully adjusted model, the odds of infertility were significantly increased by each unit increase in total cholesterol [TC; odds ratio (OR), 1.01; 95% CI, 1.01 - 1.01; P = 0.03] and hip circumference (HC; OR, 1.06; 95% CI, 1.00 - 1.12; P = 0.02), respectively.

Conclusions: The prevalence of self-reported male infertility was 6.42%. Male infertility was positively associated with TC and HC, indicating that knowledge about these risks might assist health care professionals and governments in developing and executing measures to change the status quo.

背景:男性不育是一个日益严重的健康问题。有人认为不孕症与某些代谢异常有关。目的:本研究旨在调查自我报告的男性不育症和相关代谢紊乱的患病率。方法:这是德黑兰脂质和葡萄糖研究(TLGS)的横断面分析。共有1526名男性参与了这项研究。使用Logistic回归来检查与自我报告的男性不育症相关的代谢因素。结果:自述男性不育症总患病率为6.42%。可育男性和不育男性的平均体重指数(BMI)分别为26.80(3.93)和26.92(4.36)。两组的大多数参与者年龄在40-50岁之间。在完全调整模型中,总胆固醇每增加一个单位,不孕的几率显著增加[TC;优势比(OR), 1.01;95% ci, 1.01 - 1.01;P = 0.03]和臀围(HC;或者,1.06;95% ci, 1.00 - 1.12;P = 0.02)。结论:自述男性不育症患病率为6.42%。男性不育与TC和HC呈正相关,表明了解这些风险可能有助于卫生保健专业人员和政府制定和执行改变现状的措施。
{"title":"Self-reported Male Infertility and Metabolic Disturbance: A Cross-Sectional Study.","authors":"Mahbanoo Farhadi-Azar,&nbsp;Marzieh Saei Ghare Naz,&nbsp;Mehrdad Ghahremani,&nbsp;Maryam Mousavi,&nbsp;Fereidoun Azizi,&nbsp;Fahimeh Ramezani Tehrani","doi":"10.5812/ijem-134895","DOIUrl":"https://doi.org/10.5812/ijem-134895","url":null,"abstract":"<p><strong>Background: </strong>Male infertility is a growing health problem. It is proposed that infertility is associated with some metabolic abnormalities.</p><p><strong>Objectives: </strong>This study aimed to examine the prevalence of self-reported male infertility and related metabolic disturbances.</p><p><strong>Methods: </strong>This is a cross-sectional analysis of the Tehran Lipid and Glucose Study (TLGS). A total of 1526 males participated in the study. Logistic regression was used to examine metabolic factors associated with self-reported male infertility.</p><p><strong>Results: </strong>The total prevalence of self-reported male infertility was 6.42%. The mean (SD) body mass index (BMI) of participants among fertile and infertile males was 26.80 (3.93) and 26.92 (4.36), respectively. The majority of participants in both groups were in the age group of 40-50 years old. In the fully adjusted model, the odds of infertility were significantly increased by each unit increase in total cholesterol [TC; odds ratio (OR), 1.01; 95% CI, 1.01 - 1.01; P = 0.03] and hip circumference (HC; OR, 1.06; 95% CI, 1.00 - 1.12; P = 0.02), respectively.</p><p><strong>Conclusions: </strong>The prevalence of self-reported male infertility was 6.42%. Male infertility was positively associated with TC and HC, indicating that knowledge about these risks might assist health care professionals and governments in developing and executing measures to change the status quo.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/de/ijem-21-2-134895.PMC10467580.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10136682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neck Ganglioneuroma Mimicking a Thyroid Nodule in a Four-Year-Old Child: A Case Report and Review of the Literature. 1例4岁儿童颈部神经节神经瘤伴甲状腺结节:1例报告及文献复习。
IF 2.1 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5812/ijem-126486
Stefania Corrado, Cesare Morgante, Sauro Tassi, Francesco Maccarrone, Gianluca Di Massa, Alfredo Pontecorvi, Giampaolo Papi

Introduction: Ganglioneuromas are tumors of neurogenic origin usually located in the abdomen, the adrenal glands, and the mediastinum but infrequently found in the neck region.

Case presentation: We describe the case of a four-year-old Albanian girl presenting with an anterior neck mass initially suspected to be a thyroid nodule. From a clinical point of view, there was no evidence of compression on vital cervical structures. Lab tests detected normal serum thyrotropin, calcitonin, and parathormone concentrations. A neck ultrasound showed a huge mass apparently originating from the left thyroid lobe. Cytological examination of fine needle biopsy demonstrated a population of large cells with eosinophilic cytoplasm, regular nuclei, and prominent nucleoli and spindle cells without significant atypia, consistent with a benign lesion of neurogenic origin. Also, the neck MRI displayed a mass with well-defined margins, likely arising from the peripheral nervous system. The patient underwent surgical excision of the mass without complications. The histological exam was diagnostic for ganglioneuroma.

Conclusions: We discuss the cytological and histological features peculiar to such a rare neck lesion and review the differential diagnosis.

神经节神经瘤是一种神经源性肿瘤,通常位于腹部、肾上腺和纵隔,但很少发生在颈部。病例介绍:我们描述了一个四岁的阿尔巴尼亚女孩的情况下,提出了一个前颈部肿块最初怀疑是甲状腺结节。从临床角度来看,没有证据表明颈椎重要结构受到压迫。实验室检测血清促甲状腺素、降钙素和甲状旁腺激素浓度正常。颈部超音波显示一巨大肿块,明显源自左甲状腺叶。细针活检细胞学检查显示大细胞群嗜酸性细胞质,细胞核规则,核仁和梭形细胞突出,无明显异型性,符合神经源性良性病变。同时,颈部MRI显示肿块边界清晰,可能来自周围神经系统。患者接受手术切除肿块,无并发症。组织学检查诊断为神经节神经瘤。结论:我们讨论了这种罕见的颈部病变的细胞学和组织学特征,并回顾了鉴别诊断。
{"title":"Neck Ganglioneuroma Mimicking a Thyroid Nodule in a Four-Year-Old Child: A Case Report and Review of the Literature.","authors":"Stefania Corrado,&nbsp;Cesare Morgante,&nbsp;Sauro Tassi,&nbsp;Francesco Maccarrone,&nbsp;Gianluca Di Massa,&nbsp;Alfredo Pontecorvi,&nbsp;Giampaolo Papi","doi":"10.5812/ijem-126486","DOIUrl":"https://doi.org/10.5812/ijem-126486","url":null,"abstract":"<p><strong>Introduction: </strong>Ganglioneuromas are tumors of neurogenic origin usually located in the abdomen, the adrenal glands, and the mediastinum but infrequently found in the neck region.</p><p><strong>Case presentation: </strong>We describe the case of a four-year-old Albanian girl presenting with an anterior neck mass initially suspected to be a thyroid nodule. From a clinical point of view, there was no evidence of compression on vital cervical structures. Lab tests detected normal serum thyrotropin, calcitonin, and parathormone concentrations. A neck ultrasound showed a huge mass apparently originating from the left thyroid lobe. Cytological examination of fine needle biopsy demonstrated a population of large cells with eosinophilic cytoplasm, regular nuclei, and prominent nucleoli and spindle cells without significant atypia, consistent with a benign lesion of neurogenic origin. Also, the neck MRI displayed a mass with well-defined margins, likely arising from the peripheral nervous system. The patient underwent surgical excision of the mass without complications. The histological exam was diagnostic for ganglioneuroma.</p><p><strong>Conclusions: </strong>We discuss the cytological and histological features peculiar to such a rare neck lesion and review the differential diagnosis.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/eb/ijem-21-2-126486.PMC10474842.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10151319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Endocrinology and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1